Sfoglia per AUTORE
CANALIS C
Collezione ASL Vercelli
Items : 1
A multi-center comparative study of Atezolizumab plus Bevacivumab and Lenvatinib as primary systemic therapy for unresectable hepatocellular carcinoma (HCC): focus on thrombotic and hemorrhagic adverse events in Digestive and Liver Disease
2024
ASL Vercelli
ASL Vercelli
Tizzani M; Mazzarelli C; Burlone M; Carucci P; Caviglia GP; Lisi C; Canalis C; Cesarini L; Pirisi M; Acquaviva A; Rolle E; Pochettino P; Bencardino K; Villa F; Angiolillo M; Scaldaferri M; Castellana E; Cattel F; Airoldi M; Saracco GM; Gaia S;